Both in Biotechnology
Ginkgo Bioworks Holdings vs MeiraGTx Holdings
Over the past year DNA returned −13.7% and MGTX returned +4.5%; their daily moves had a correlation of 0.26.
DNA −13.7% MGTX +4.5%Growth of $1, one year, split-adjusted
| Metric | DNA | MGTX |
|---|---|---|
| Price | $11.21 | $9.49 |
| Market cap | $754.9M | $911.4M |
| Today | −12.01% | −2.22% |
| 1 month | −10.3% | −11.0% |
| 6 months | +15.6% | +0.9% |
| Year to date | +34.9% | +19.4% |
| 1 year | −8.0% | +6.3% |
| Revenue growth (YoY) | −48.5% | +8608.6% |
| Gross margin | 91.5% | 97.8% |
| Net margin | −231.7% | 50.0% |
| P/E (TTM) | — | 11.5× |
| Price / sales | 6.7× | 2.3× |
| Net cash | $302.2M | $21.8M |
| Dividend yield | — | — |
| Volatility (60d) | 125.2% | 47.5% |
| Short % of float | 18.4% | 10.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).